Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $8.97B |
| FY2017, ended Dec 31, 2017 | $25.2B |
| FY2018, ended Dec 31, 2018 | $21.0B |
| FY2019, ended Dec 31, 2019 | $30.8B |
| FY2020, ended Dec 31, 2020 | $30.9B |
| FY2021, ended Dec 31, 2021 | $43.5B |
| FY2022, ended Dec 31, 2022 | $33.7B |
| FY2023, ended Dec 31, 2023 | $45.9B |
| FY2024, ended Dec 31, 2024 | $59.5B |
| FY2025, ended Dec 31, 2025 | $65.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $70.8B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.58B |
| FY2017, ended Dec 31, 2017 | $8.13B |
| FY2018, ended Dec 31, 2018 | $8.91B |
| FY2019, ended Dec 31, 2019 | $9.45B |
| FY2020, ended Dec 31, 2020 | $4.31B |
| FY2021, ended Dec 31, 2021 | $5.79B |
| FY2022, ended Dec 31, 2022 | $8.77B |
| FY2023, ended Dec 31, 2023 | $10.2B |
| FY2024, ended Dec 31, 2024 | $11.2B |
| FY2025, ended Dec 31, 2025 | $12.0B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $12.7B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $338M | $993M |
| FY2017, ended Dec 31, 2017 | $1.08B | $791M |
| FY2018, ended Dec 31, 2018 | $764M | $1.18B |
| FY2019, ended Dec 31, 2019 | $881M | $1.30B |
| FY2020, ended Dec 31, 2020 | −$715M | $662M |
| FY2021, ended Dec 31, 2021 | $410M | $74.0M |
| FY2022, ended Dec 31, 2022 | $1.25B | $1.64B |
| FY2023, ended Dec 31, 2023 | $1.14B | $1.79B |
| FY2024, ended Dec 31, 2024 | $1.53B | $1.92B |
| FY2025, ended Dec 31, 2025 | $1.46B | $2.03B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.70B | $1.93B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.06B |
| FY2017, ended Dec 31, 2017 | $570M |
| FY2018, ended Dec 31, 2018 | $403M |
| FY2019, ended Dec 31, 2019 | $538M |
| FY2020, ended Dec 31, 2020 | $3.22B |
| FY2021, ended Dec 31, 2021 | $1.43B |
| FY2022, ended Dec 31, 2022 | $1.21B |
| FY2023, ended Dec 31, 2023 | $800M |
| FY2024, ended Dec 31, 2024 | $1.30B |
| FY2025, ended Dec 31, 2025 | $918M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $774M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.62B |
| FY2017, ended Dec 31, 2017 | $6.60B |
| FY2018, ended Dec 31, 2018 | $7.28B |
| FY2019, ended Dec 31, 2019 | $7.99B |
| FY2020, ended Dec 31, 2020 | $10.5B |
| FY2021, ended Dec 31, 2021 | $8.77B |
| FY2022, ended Dec 31, 2022 | $8.75B |
| FY2023, ended Dec 31, 2023 | $9.20B |
| FY2024, ended Dec 31, 2024 | $11.2B |
| FY2025, ended Dec 31, 2025 | $12.4B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $13.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 32.5% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 330M |
| FY2017, ended Dec 31, 2017 | 316M |
| FY2018, ended Dec 31, 2018 | 293M |
| FY2019, ended Dec 31, 2019 | 277M |
| FY2020, ended Dec 31, 2020 | 278M |
| FY2021, ended Dec 31, 2021 | 279M |
| FY2022, ended Dec 31, 2022 | 266M |
| FY2023, ended Dec 31, 2023 | 252M |
| FY2024, ended Dec 31, 2024 | 241M |
| FY2025, ended Dec 31, 2025 | 229M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 223M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $0 | $91.0M |
| FY2017, ended Dec 31, 2017 | $891M | $121M |
| FY2018, ended Dec 31, 2018 | $1.72B | $127M |
| FY2019, ended Dec 31, 2019 | $1.54B | $154M |
| FY2020, ended Dec 31, 2020 | $296M | $97.0M |
| FY2021, ended Dec 31, 2021 | $0 | $193M |
| FY2022, ended Dec 31, 2022 | $1.59B | $162M |
| FY2023, ended Dec 31, 2023 | $2.34B | $169M |
| FY2024, ended Dec 31, 2024 | $2.89B | $176M |
| FY2025, ended Dec 31, 2025 | $3.18B | $170M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.41B | $200M |
Valuation
At current price- Market Cap
- $76.7B
- P/E
- 45.1×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.0×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- 27.5×
Growth
Trailing 12 months- Revenue (TTM)
- $12.7B
- Revenue Growth YoY
- 8.1%
- Revenue CAGR 3Y
- 11.1%
- Revenue CAGR 5Y
- 22.8%
- EPS Growth YoY
- 7.5%
- Net Income Growth YoY
- 2.1%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 24.0%
- Net Margin
- 13.4%
- FCF Margin
- 15.2%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $1.70B
- EPS (diluted)
- $7.41
- EBITDA
- $3.25B
- Operating Income
- $3.05B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $774M
- Total Debt
- $13.4B
- Net Debt
- $12.6B
- Total Assets
- $16.8B
- Total Liabilities
- $23.4B
- Shareholders' Equity
- −$6.59B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $2.01B
- Capital Expenditure
- $83.0M
- Free Cash Flow
- $1.93B
Dividends and risk
Last 12 months- Dividend Yield
- 0.2%
- Dividend / Share
- $0.60
- Beta (5Y)
- 1.10
Every ratio is calculated from the company’s reported figures.